Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Penile Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1HIV Infections 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Fluorouracil 3Watchful Waiting 2Observation 2Cisplatin 2human papillomavirus vaccine, L1 type 16, 18 1Transurethral Resection of Prostate 1Radiotherapy 1Proctoscopy 1Papillomavirus Vaccines 1Mass Screening 1Light Coagulation 1Laser Therapy 1Isotretinoin 1Interviews as Topic 1Imiquimod 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1HIV Testing 1Focus Groups 1Data Collection 1Colposcopy 1Blood Specimen Collection 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Isotretinoin × Gynecologic × Clear all
NCT00001073 2021-11-04

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
150 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡